Overview:
Although topical therapies are a common approach for glaucoma, they can drive ocular surface adverse events, and many patients have difficulty accurately administering and adhering to them. Given the unmet needs of topical therapies, this program will explore new and emerging MIGS and MIBS procedures, implants, and comanagement opportunities—all of which have the potential to substantially improve outcomes in glaucoma patients.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Discuss the benefits of diagnostic tools and imaging modalities in glaucoma management
- Describe the various surgical techniques for glaucoma management based on their mechanisms, safety profiles, and clinical outcomes
- Apply patient selection criteria to determine the appropriate minimally invasive glaucoma surgery (MIGS) and procedural pharmaceutical approaches for individuals with varying glaucoma severity
- Implement optimal strategies for comanagement of glaucoma between optometrists and ophthalmologists
Lorraine M. Provencher, MD
Ophthalmologist
Vance Thompson Vision
Omaha, NE
Brandon J. Baartman, MD
Corneal, Cataract, Glaucoma & Refractive Surgeon
Vance Thompson Vision
Omaha, NE
Brian Shafer, MD
Shafer Vision Institute, Founder and CEO
Adjunct Assistant Professor of Ophthalmology, University of Pennsylvania
Adjunct Assistant Professor of Ophthalmology, Temple University
Clinical Instructor, Wills Eye Hospital
Kristen Walton, OD, FAAO
Optometrist
Vance Thompson Vision
Omaha, NE
Physicians’ Education Resource®, LLC is accredited by COPE to provide continuing education to optometrists.
Physicians’ Education Resource®, LLC, designates this activity for a maximum of 1.0 COPE credit.